DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Apricitabine is an investigational drug.
There have been 6 clinical trials for Apricitabine. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2008.
The most common disease conditions in clinical trials are HIV Infections, Infection, and Communicable Diseases. The leading clinical trial sponsors are Avexa and [disabled in preview].
Recent Clinical Trials for Apricitabine
|A Long Term Safety Study of Apricitabine in HIV-infected Patients||Avexa||Phase 3|
|Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection||Avexa||Phase 2/Phase 3|
|A Long Term, Safety Study of Apricitabine in HIV-infected Subjects||Avexa||Phase 2|